Navigation Links
Cell Line Nucleofector Kit V from Lonza Cologne AG

ProductsCell Line Nucleofector Kit V from Lonza Cologne AG
Company Lonza Cologne AG
Item Cell Line Nucleofector Kit V
Price 
Description For nucleofection of optimized cell lines in combination with the corresponding optimized protocol including the nucleofection parameters. Nucleofector Kits are only functional in combination with the Nucleofector Device.

Different cell lines can be transfected with this kit. The corresponding efficiencies and viabilities are given in brackets in percent (Efficiency [%] / viability [%]).

Cell Lines:
3T3-L1 pre-ad (73/59)
293 (ATCC) (84/---)
293 (DSMZ) (57/---)
32D (ATCC) (79/61)
A20 (ATCC) (74/81)
AGS (ATCC) (73/62)
ARPE-19 (ATCC) (83/92)
BA/F3 (DSMZ) (88/80)
C2C12 (ATCC) (82/67)
C6 (ATCC) (87/80)
COS-1 (ATCC) (49/64)
COS-7 (DSMZ) (85/---)
HaCaT (DKFZ) (43/---)
HCT116 (ATCC) (78/50)
HepG2 (64/---)
HL-60 (ATCC) (50/---)
Jurkat (ATCC) (54/---)
Jurkat (DSMZ) (68/---)
K562 (ATCC) (89/---)
K562 (DSMZ) (79/---)
MCF-7 (ATCC) (71/---)
MDA-MB231 (ATCC) (80/77)
MDA-MB468 (ATCC) (60/94)
NCTC clone 929 (ATCC) (67/91)
Neuro-2a (ATCC) (76/79)
P19 (ATCC) (85/80)
PC12 (34/---)
PC-3 (ATCC) (81/60)
Raji (ATCC) (58/67)
Ramos (ATCC) (27/72)
RAW 264.7 (65/74)
RBL-1 (ATCC) (84/67)
Saos-2 (ATCC) (82/79)
SH-SY5Y (ATCC) (82/60)
SK-N-SH (ATCC) (85/73)
SK-OV-3 (ATCC) (89/60)
sus.CHO (ECACC) (92/80)
SW480 (ATCC) (60/86)
T-47D (ATCC) (51/94)
THP-1 (ATCC) (67/60)
U-2 OS (ATCC) (98/88)
U937 (ATCC) (56/50)
Vero (ATCC) (79/97)

If your cell line is not listed, please consult our cell database at the link below.

Info Lonza Cologne AG

Nattermannallee 1
50829 Koeln
Germany

Customer Service: 49 (0)221-99199-0
Fax Number: 49 (0)221-99199-111
Web Site: http://www.lonza.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Cell Line Nucleofector Kit T from Lonza Cologne AG
... rapid analytical to medium scale affinity purification ... vectors. Sufficient reagents are provided for purification ... under native or denaturing conditions. Crude samples ... retains STag fusion proteins. After unbound proteins ...
Request Info...
... aa 16-25 of human GSK3 alpha. ... Store vial at -20 C prior to opening. Dilute ... and freeze at -20 C or below. Avoid cycles ... Sub-Family: not assigned-Other ...
... Physical form: Essentially sulfate-free, powder ... Preparation Unit Definition: One ... D -fructose 6-phosphate to ... pH 7.4 at 25 C. ...
Biology Products:
(Date:3/7/2017)... LAKE CITY , March 7, 2017   ... that help top global companies identify the best talent, ... as Chief Sales Officer (CSO) and Diana ... Kucer,s appointments round out a seasoned executive team poised to ... and beyond, building on a year of record bookings ...
(Date:3/2/2017)... 2, 2017 Who risk to be deprived ... the full report: https://www.reportbuyer.com/product/4313699/ WILL APPLE ... FIELD? Fingerprint sensors using capacitive technology represent a ... vendor Idex forecasts an increase of 360% of the ... of the fingerprint sensor market between 2014 and 2017 ...
(Date:2/28/2017)... News solutions for biometrics, bag drop and ... ... to 16 March, Materna will present its complete end-to-end passenger ... is a real benefit for passengers. To accelerate the whole ... touch point solutions to take passengers through the complete integrated ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... ... March 27, 2017 , ... IsoPlexis ... against cancer, autoimmune disease and more through a single-cell precision engineering platform, today ... analysis platform developed in the laboratory of Dr. James Heath at the ...
(Date:3/27/2017)... , March 27, 2017  The global ... for 2016, according to a new report from ... lab testing is performed to evaluate disease progression, ... therapy, among other reasons.  The healthcare market research ... , provides an overview of the medical ...
(Date:3/27/2017)... Cambridge, MA (PRWEB) , ... March 27, 2017 ... ... published a method to engineer scalable and customizable vascular grafts in JoVE’s Video ... that may lead to new and improved ways of treating coronary artery disease ...
(Date:3/24/2017)... MiMedx Group, Inc. (NASDAQ: MDXG), the leading ... allografts and patent-protected processes to develop and market advanced ... today  that it will present at the Needham Healthcare ... Parker H. "Pete" Petit, Chairman and CEO, Michael ... Cashman , EVP and Chief Commercialization Officer, and ...
Breaking Biology Technology: